MENU
TARS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Tarsus Pharmaceuticals (TARS) Earnings Date & Reports

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care... Show more

A.I. Advisor
published Earnings

TARS is expected to report earnings to fall 41.25% to -28 cents per share on November 05

Tarsus Pharmaceuticals TARS Stock Earnings Reports
Q3'25
Est.
$-0.28
Q2'25
Missed
by $0.10
Q1'25
Beat
by $0.15
Q4'24
Beat
by $0.17
Q3'24
Beat
by $0.33
The last earnings report on August 06 showed earnings per share of -47 cents, missing the estimate of -37 cents. With 479.32K shares outstanding, the current market capitalization sits at 2.02B.
View a ticker or compare two or three
TARS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TARS showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
15440 Laguna Canyon Road
Phone
+1 949 409-9820
Employees
244
Web
https://www.tarsusrx.com